Drug Type Antibody |
Synonyms- |
Target |
Mechanism IL-6 inhibitors(Interleukin-6 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic macular oedema | Preclinical | US | 01 Apr 2014 |